Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Big pharmaceutical companies investing in oligonucleotide therapeutics for drug development
4.2.2 Increased involvement of CMOs in manufacturing therapeutic oligonucleotides.
4.2.3 Wide application areas offered by the oligonucleotides
4.3 Restraints
4.3.1 Complexity in the manufacturing technique and inaccuracy of oligonucleotides.
4.4 Opportunities
5 Market Factor Analysis
5.1 Porters Five forces Model
5.1.1 Bargaining power of suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
6 Global Oligonucleotide Pool Market by Type
6.1 Introduction
7 Global Oligonucleotide Pool Market by Application
7.1 Introduction
8 Global Oligonucleotide Pool Market by End User
8.1 Introduction
9 Global Oligonucleotide Pool Market by Region
9.1 Introduction
9.2 North America
9.3 Europe
9.4 Asia-Pacific
9.5 Middle East & Africa
10 Competitive Landscape
10.1 Introduction
11 Company Profile
11.1 Agilent Technologies
11.1.1 Company Overview
11.1.2 Product/Business Segment Overview
11.1.3 Financial Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Creative Biogene
11.2.1 Company Overview
11.2.2 Product/Business Segment Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 CustomArray, Inc.
11.3.1 Company Overview
11.3.2 Product/Business Segment Overview
11.3.3 Financial Overview
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.4 Integrated DNA Technologies, Inc.
11.4.1 Company Overview
11.4.2 Product/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.5 MYcroarray
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financials
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Sigma-Aldrich Co. LLC
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financials
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 TriLink BioTechnologies, LLC
11.7.1 Company Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Twist Bioscience
11.8.1 Company Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis